A father's exposure to passive smoking as a child may impair the lifelong lung function of his children, putting them at risk of chronic obstructive pulmonary disease.

AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and ...

Every spring, most Americans dutifully adjust their clocks forward to daylight saving time, and every fall, back to standard ...

AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic ...

The likelihood for mortality during hospitalization was increased among those with COPD or asthma vs. asthma-COPD overlap ...

An overwhelming percentage of U.S. adults have at least one chronic health condition. Advertising Disclosure: When you buy something by clicking links within this article, we may earn a small ...

While there has been progress against chronic disease, the U.S. has been backsliding against big killers like heart disease.

In most countries, a slowdown in circulatory disease deaths drove the net decline in NCD mortality from 2010 to 2019. This ...

The American College of Chest Physicians (CHEST) and the American Lung Association (ALA) have awarded the CHEST/ALA Guideline ...

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca, in collaboration with Amgen, is ...

Sofinnova Partners leads premier investor syndicate backing Galvanize's breakthrough pulsed electric field (PEF) platform—a first-of-its-kind, non-drug approach targeting solid tumors and chronic ...